Given the risk of serotonin syndrome when methylene blue is used concomitantly with serotonergic drugs, it is crucial to monitor for symptoms such as mental status changes (e.g., agitation, hallucinations), autonomic instability (e.g., tachycardia, labile blood pressure), neuromuscular symptoms (e.g., tremor, rigidity), and gastrointestinal symptoms (e.g., nausea, diarrhea)
Thinning at the part, shedding in the shower, receding at the templeswhatever the pattern, we start by fixing whats driving it
This improper regulation of H3K9me3 contributes to the cognitive decline, motor dysfunction, and developmental regression characteristic of the disease (Tillotson and Bird, 2020)
Safety profile characterization What is the true incidence and severity of adverse events with combination therapy
(2011) Potential Beneficial Effects of Butyrate in Intestinal and Extraintestinal Diseases